RNS Number : 5053M Alyeska Investment Group, LP 15 July 2026  

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.             KEY INFORMATION

(a)   Full name of discloser

Alyeska Investment Group, LP

(b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Alyeska Master Fund, LP

(c)   Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Forward Industries, Inc

(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

N/A

(e)   Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

14 July 2026

(f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security

(Note 3)

ISIN US3499321038

$0.01 ordinary shares

Interests

Short positions

Number

%

Number

%

(1)   Relevant securities owned and/or controlled

3,148,838

4.26%

0

0

(2)   Cash-settled derivatives

0

0

0

0

(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell

0

0

0

0

Total

3,148,838

4.26%

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

Class of relevant

security

ISIN US3499321038

$0.01 ordinary shares

Purchase/sale

Sale

Number of

securities

84,015

Price per unit

(Note 5)

US$4.51

Ap29

(b)           Cash-settled derivative transactions

Class of

relevant

security

n/a

Product

description

e.g. CFD

n/a

Nature of dealing

e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

n/a

Number of

reference

securities

(Note 6)

n/a

Price

per unit

(Note 5)

n/a

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of

relevant

security

n/a

Product

description e.g. call

option

n/a

Writing, purchasing, selling, varying

etc.

n/a

Number

of

securities

to which

option

relates

(Note 6)

n/a

Exercise

price per

unit

n/a

Type

e.g.

American,

European

etc.

n/a

Expiry

date

n/a

Option

money

paid/

received per unit

n/a

(ii)           Exercise

Class of

relevant

security

n/a

Product

description

e.g. call

option

n/a

Exercising/

exercised

against

n/a

Number of

securities

n/a

Exercise

price per

unit

(Note 5)

n/a

(d)           Other dealings (including transactions in respect of new securities) (Note 3)

Class of

relevant

security

n/a

Nature of dealing

e.g. subscription,

conversion, exercise

n/a

Details

n/a

Price per unit (if

applicable)

(Note 5)

n/a

Ap30

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

  • Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

    Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

  • None

(b)           Agreements, arrangements or understandings relating to options or derivatives

  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

  • None

(c)           Attachments

  • Is a Supplemental Form 8 attached?

  • YES

Date of disclosure

15 July 2026

Contact name

Brent Cunningham

Telephone number

1-312-899-7905

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1.             KEY INFORMATION

Full name of person making

disclosure:

Alyeska Investment Group, LP

Name of offeror/offeree in relation

to whose relevant securities the

disclosure relates:

Forward Industries, Inc

2.             STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of

relevant

security

$0.01 USD Ordinary Shares

ISIN US3499321038

Product

description

e.g. call

option

Pre-funded Warrant

Written or

purchased

Purchased

Number of

securities to

which option

or derivative

relates

540,541

Exercise

price

per unit

$0.00001 USD per Warrant

Type

e.g.

American,

European

etc.

Pre-Funded Warrant

Expiry

date

Does not expire until exercise

3.             AGREEMENTS TO PURCHASE OR SELL

  • Full details should be given so that the nature of the interest or position can be fully understood:

  • N/A

Ap33

4.             RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS' AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  ITPAKPBBBBKDOOD